Experimental Brain Research

, Volume 176, Issue 4, pp 672–678 | Cite as

Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain precursor cells

  • Florian A. SiebzehnrublEmail author
  • Rolf Buslei
  • Ilker Y. Eyupoglu
  • Sebastian Seufert
  • Eric Hahnen
  • Ingmar Blumcke
Research Note


Chromatin modification plays a key role in fate decision of neural stem cells. Here, we explored the impact of epigenetic remodelling onto neuronal fate determination using specific inhibitors of histone deacetylases (iHDAC). Adult subventricular zone (SVZ) precursor cells were expanded as neurospheres and treated in vitro with second generation iHDAC MS-275, M344 and suberoylanilide hydroxamic acid (SAHA). All tested compounds revealed a significant increase of βIII-tubulin positive neurons (ranging from 258 to 431%) in a concentration-dependent manner. The number of oligodendrocytes was decreased by almost 50%, accompanied by a reduction of Olig2 mRNA expression. In contrast, astrocyte quantity remained unaffected after iHDAC treatment. Both control and iHDAC treated cells expressed markers of mature GABAergic and dopaminergic neurons. Increased expression levels of NeuroD, Cyclin D2 and B-lymphocyte translocation gene 3 (Btg3) point to a shift towards neuronal fate determination targeted by HDAC inhibitors.


Neurospheres HDAC Adult stem cells Differentiation Acetylation 



The authors thank D. Müller for excellent technical assistance. This work has been supported by the Bavarian Research Council (Munich) and the Johannes and Frieda Marohn Foundation (University of Erlangen). FAS is a fellow of the Studienstiftung des deutschen Volkes e.V. (German national merit foundation).


  1. Angelastro JM, Ignatova TN, Kukekov VG, Steindler DA, Stengren GB, Mendelsohn C, Greene LA (2003) Regulated expression of ATF5 is required for the progression of neural progenitor cells to neurons. J Neurosci 23:4590–4600PubMedGoogle Scholar
  2. Baker GL, Landis MW, Hinds PW (2005) Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation. Cell Cycle 4:330–338PubMedGoogle Scholar
  3. Canzoniere D, Farioli-Vecchioli S, Conti F, Ciotti MT, Tata AM, Augusti-Tocco G, Mattei E, Lakshmana MK, Krizhanovsky V, Reeves SA, Giovannoni R, Castano F, Servadio A, Ben-Arie N, Tirone F (2004) Dual control of neurogenesis by PC3 through cell cycle inhibition and induction of Math1. J Neurosci 24:3355–3369CrossRefPubMedGoogle Scholar
  4. Cunliffe VT, Casaccia-Bonnefil P (2006) Histone deacetylase 1 is essential for oligodendrocyte specification in the zebrafish CNS. Mech Dev 123:24–30CrossRefPubMedGoogle Scholar
  5. Doetsch F, Garcia-Verdugo JM, Alvarez-Buylla A (1997) Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci 17:5046–5061PubMedGoogle Scholar
  6. Eyupoglu IY, Hahnen E, Buslei R, Siebzehnrubl FA, Savaskan NE, Luders M, Trankle C, Wick W, Weller M, Fahlbusch R, Blumcke I (2005) Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo. J Neurochem 93:992–999CrossRefPubMedGoogle Scholar
  7. Gage FH (2000) Mammalian neural stem cells. Science 287:1433–1438CrossRefPubMedGoogle Scholar
  8. Guardavaccaro D, Corrente G, Covone F, Micheli L, D’Agnano I, Starace G, Caruso M, Tirone F (2000) Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol 20:1797–1815CrossRefPubMedGoogle Scholar
  9. Hack MA, Saghatelyan A, de Chevigny A, Pfeifer A, Ashery-Padan R, Lledo PM, Gotz M (2005) Neuronal fate determinants of adult olfactory bulb neurogenesis. Nat Neurosci 8:865–872PubMedGoogle Scholar
  10. Hahnen E, Eyupoglu IY, Brichta L, Haastert K, Trankle C, Siebzehnrubl FA, Riessland M, Holker I, Claus P, Romstock J, Buslei R, Wirth B, Blumcke I (2006) In vitro and ex vivo evaluation of second generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy. J Neurochem 98:193–202CrossRefPubMedGoogle Scholar
  11. Hao Y, Creson T, Zhang L, Li P, Du F, Yuan P, Gould TD, Manji HK, Chen G (2004) Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J Neurosci 24:6590–6599CrossRefPubMedGoogle Scholar
  12. Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH (2004) Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci USA 101:16659–16664CrossRefPubMedGoogle Scholar
  13. Kim SM, Yang JW, Park MJ, Lee JK, Kim SU, Lee YS, Lee MA (2006) Regulation of human tyrosine hydroxylase gene by neuron-restrictive silencer factor. Biochem Biophys Res Commun 346:426–435CrossRefPubMedGoogle Scholar
  14. Kowalczyk A, Filipkowski RK, Rylski M, Wilczynski GM, Konopacki FA, Jaworski J, Ciemerych MA, Sicinski P, Kaczmarek L (2004) The critical role of cyclin D2 in adult neurogenesis. J Cell Biol 167:209–213CrossRefPubMedGoogle Scholar
  15. Laeng P, Pitts RL, Lemire AL, Drabik CE, Weiner A, Tang H, Thyagarajan R, Mallon BS, Altar CA (2004) The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J Neurochem 91:238–251CrossRefPubMedGoogle Scholar
  16. Ligon KL, Fancy SP, Franklin RJ, Rowitch DH (2006) Olig gene function in CNS development and disease. Glia 54:1–10CrossRefPubMedGoogle Scholar
  17. Marin-Husstege M, Muggironi M, Liu A, Casaccia-Bonnefil P (2002) Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J Neurosci 22:10333–10345PubMedGoogle Scholar
  18. Marks PA, Jiang X (2005) Histone deacetylase inhibitors in programmed cell death and cancer therapy. Cell Cycle 4:549–551PubMedGoogle Scholar
  19. Marks PA, Miller T, Richon VM (2003) Histone deacetylases. Curr Opin Pharmacol 3:344–351CrossRefPubMedGoogle Scholar
  20. Mason JL, Angelastro JM, Ignatova TN, Kukekov VG, Lin G, Greene LA, Goldman JE (2005) ATF5 regulates the proliferation and differentiation of oligodendrocytes. Mol Cell Neurosci 29:372–380CrossRefPubMedGoogle Scholar
  21. Miller TA, Witter DJ, Belvedere S (2003) Histone deacetylase inhibitors. J Med Chem 46:5097–5116CrossRefPubMedGoogle Scholar
  22. Ming GL, Song H (2005) Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 28:223–250CrossRefPubMedGoogle Scholar
  23. Naruse Y, Aoki T, Kojima T, Mori N (1999) Neural restrictive silencer factor recruits mSin3 and histone deacetylase complex to repress neuron-specific target genes. Proc Natl Acad Sci USA 96:13691–13696CrossRefPubMedGoogle Scholar
  24. Park JH, Jung Y, Kim TY, Kim SG, Jong HS, Lee JW, Kim DK, Lee JS, Kim NK, Bang YJ (2004) Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation. Clin Cancer Res 10:5271–5281CrossRefPubMedGoogle Scholar
  25. Peterson CL, Laniel MA (2004) Histones and histone modifications. Curr Biol 14:R546–551CrossRefPubMedGoogle Scholar
  26. Sumrejkanchanakij P, Tamamori-Adachi M, Matsunaga Y, Eto K, Ikeda MA (2003) Role of cyclin D1 cytoplasmic sequestration in the survival of postmitotic neurons. Oncogene 22:8723–8730CrossRefPubMedGoogle Scholar
  27. Tirone F (2001) The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair? J Cell Physiol 187:155–165CrossRefPubMedGoogle Scholar
  28. Wachs FP, Couillard-Despres S, Engelhardt M, Wilhelm D, Ploetz S, Vroemen M, Kaesbauer J, Uyanik G, Klucken J, Karl C, Tebbing J, Svendsen C, Weidner N, Kuhn HG, Winkler J, Aigner L (2003) High efficacy of clonal growth and expansion of adult neural stem cells. Lab Invest 83:949–962CrossRefPubMedGoogle Scholar
  29. Yoshida Y, Matsuda S, Ikematsu N, Kawamura-Tsuzuku J, Inazawa J, Umemori H, Yamamoto T (1998) ANA, a novel member of Tob/BTG1 family, is expressed in the ventricular zone of the developing central nervous system. Oncogene 16:2687–2693CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Florian A. Siebzehnrubl
    • 1
    Email author
  • Rolf Buslei
    • 1
  • Ilker Y. Eyupoglu
    • 2
  • Sebastian Seufert
    • 3
  • Eric Hahnen
    • 1
    • 3
  • Ingmar Blumcke
    • 1
  1. 1.Department of NeuropathologyUniversity of Erlangen-NurembergErlangenGermany
  2. 2.Department of NeurosurgeryUniversity of Erlangen-NurembergErlangenGermany
  3. 3.Institute of Genetics, Institute of Human Genetics and Center for Molecular Medicine Cologne (CMMC)University of CologneCologneGermany

Personalised recommendations